193 related articles for article (PubMed ID: 9192124)
41. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
[TBL] [Abstract][Full Text] [Related]
42. Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Bowles MJ; Smith L; Glover DR
J Hum Hypertens; 1990 Jun; 4 Suppl 2():85-90. PubMed ID: 2196372
[TBL] [Abstract][Full Text] [Related]
43. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
[TBL] [Abstract][Full Text] [Related]
44. Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.
Burger W; Hampel C; Kaltenbach M; Hartmann A; Herrmann M; Hoffmann JA; Klepzig H
Am J Cardiol; 2000 Jan; 85(2):172-7. PubMed ID: 10955372
[TBL] [Abstract][Full Text] [Related]
45. Role of cardiac beta 2-receptors in cardiac responses to exercise in cardiac transplant patients.
Leenen FH; Davies RA; Fourney A
Circulation; 1995 Feb; 91(3):685-90. PubMed ID: 7828294
[TBL] [Abstract][Full Text] [Related]
46. Perceived exertion and gas exchange after calcium and beta-blockade in atrial fibrillation.
Myers J; Atwood JE; Sullivan M; Forbes S; Friis R; Pewen W; Froelicher V
J Appl Physiol (1985); 1987 Jul; 63(1):97-104. PubMed ID: 2887542
[TBL] [Abstract][Full Text] [Related]
47. Effect of beta-adrenoceptor blockade on postexercise oxygen consumption and triglyceride/fatty acid cycling.
Børsheim E; Bahr R; Høstmark AT; Knardahl S
Metabolism; 1998 Apr; 47(4):439-48. PubMed ID: 9550543
[TBL] [Abstract][Full Text] [Related]
48. [Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)].
Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
Wien Klin Wochenschr; 1978 May; 90(10):350-4. PubMed ID: 26139
[TBL] [Abstract][Full Text] [Related]
49. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
Kaiser P; Hylander B; Eliasson K; Kaijser L
Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
[TBL] [Abstract][Full Text] [Related]
50. Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise.
Cosenzi A; Sacerdote A; Bocin E; Molino R; Mangiarotti M; Bellini G
J Cardiovasc Pharmacol; 1995 Jan; 25(1):142-6. PubMed ID: 7723344
[TBL] [Abstract][Full Text] [Related]
51. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
52. beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol.
Hiatt WR; Wolfel EE; Stoll S; Nies AS; Zerbe GO; Brammell HL; Horwitz LD
Clin Pharmacol Ther; 1985 Jan; 37(1):2-6. PubMed ID: 2856902
[TBL] [Abstract][Full Text] [Related]
53. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol.
Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG
Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309
[TBL] [Abstract][Full Text] [Related]
54. Cardio-protection afforded by β-blockade is maintained during resistance exercise.
Conviser JM; Ng AV; Rockey SS; Thomas DP
J Sci Med Sport; 2017 Feb; 20(2):196-201. PubMed ID: 27012728
[TBL] [Abstract][Full Text] [Related]
55. Improved left ventricular function during exercise: a comparison of celiprolol and atenolol.
McLenachan J; Wilson J; Dargie H
Am Heart J; 1988 Nov; 116(5 Pt 2):1435-6. PubMed ID: 2903655
[No Abstract] [Full Text] [Related]
56. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
[TBL] [Abstract][Full Text] [Related]
57. Influence of beta-blocker use on percentage of target heart rate exercise prescription.
Wonisch M; Hofmann P; Fruhwald FM; Kraxner W; Hödl R; Pokan R; Klein W
Eur J Cardiovasc Prev Rehabil; 2003 Aug; 10(4):296-301. PubMed ID: 14555886
[TBL] [Abstract][Full Text] [Related]
58. Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade.
Fletcher GF; Sweeney ME; Fletcher BJ
Am Heart J; 1991 Jan; 121(1 Pt 1):105-10. PubMed ID: 1670740
[TBL] [Abstract][Full Text] [Related]
59. Clinical pharmacology of vasodilatory beta-blocking drugs.
Shanks RG
Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
[TBL] [Abstract][Full Text] [Related]
60. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.
Witchitz S; Cohen-Solal A; Dartois N; Weisslinger N; Juste K; Darmon JY
Am J Cardiol; 2000 Jun; 85(12):1467-71. PubMed ID: 10856394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
